Position history for WELLS FARGO & COMPANY/MN's holdings in AVIDITY BIOSCIENCES INC
WELLS FARGO & COMPANY/MN holds 210,604 shares of RNA (AVIDITY BIOSCIENCES INC), worth $15.2M as of 2025-Q4. The position was decreased (-31.5% shares). RNA represents 0.0% of WELLS FARGO & COMPANY/MN's portfolio.
Current Value
$15.2M
Current Shares
210,604
Total Value Change
+$9.7M
Total Shares Change
+76,731
Other major holders of RNA: VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
Decreased |
| 210,604 |
-31.5% |
| $15.2M |
| 0.0% |
| $72.15 |
0 |
| 2025-Q3 | Increased | 307,394 | +20.3% | $13.4M | 0.0% | $42.63 | 33 |
| 2025-Q2 | Increased | 255,598 | +15.8% | $7.3M | 0.0% | $29.03 | 32 |
| 2025-Q1 | Increased | 220,786 | +27.9% | $6.5M | 0.0% | $31.60 | 34 |
| 2024-Q4 | Decreased | 172,570 | -1.6% | $5M | 0.0% | $29.18 | 0 |
| 2024-Q3 | Increased | 175,341 | +31.0% | $8.1M | 0.0% | $42.33 | 35 |
| 2024-Q2 | Decreased | 133,873 | -15.3% | $5.5M | 0.0% | $40.85 | 0 |